There is growing interest in patient safety in health care. This review sought to identify any dental research in this area, only a small number of studies were identified demonstrating the need for further research
[read the full story...]
This technology review looked at the effectiveness of crowns on root treated teeth. 3 systematic reviews and 4 non-randomised studies were included. They found that the short term survival with crowns or direct fillings is comparable but long term root canal treated teeth may have better survival.
[read the full story...]
Chris Sampson reports on a new HTA systematic review and economic evaluation of art therapy for non-psychotic mental health disorders like depression, anxiety and phobias.
[read the full story...]
Can we steer drug-using offenders away from crime and into treatment? Chris Sampson explores a study of the cost-effectiveness of diversion and aftercare programmes for offenders using class A drugs.
[read the full story...]
Clarissa Giebel tackles a randomised controlled trial (RCT) of telecare assistive technology and examines the findings on cost effectiveness and quality of life.
[read the full story...]
Bipolar disorder is associated with high economic costs…or is it? Chris Sampson reports on a new systematic review, which highlights limitations in our understanding.
[read the full story...]
A recent report estimated the societal cost of perinatal mental health problems to be £8 billion, but should we believe it? Chris Sampson advises caution.
[read the full story...]
Dave Steele summarises an NIHR funded mixed methods study that concludes we don’t know much about how we should support older adults with mental health problems, except to say that we should be doing better.
[read the full story...]
Chris Sampson reports on a recent systematic review and critical appraisal of economic evaluations in bipolar disorder. He finds that there’s a pressing need for new studies, especially discrete event simulations.
[read the full story...]
Andrew Jones and Chris Sampson report on a systematic review and economic evaluation of cytisine and varenicline for smoking cessation, which finds that both drugs are clinically effective compared with placebo.
[read the full story...]
